Green Chip Stocks Appearances

Pot Stocks Continue to Get Murdered

Pot Stock Investors Frustrated as Stocks Continue to Fall

By Jeff Siegel on December 13, 2018
Pot Stock Investors Frustrated as Stocks Continue to Fall

The Top 5 Renewable Energy Stocks for 2019

5 Renewable Energy Stocks to Own for 2019

By Jeff Siegel on December 13, 2018
In 2019, energy investors will need to add more exposure to the renewable energy space. Energy and Capital editor Jeff Siegel talks the end of coal's dominance and the energy stocks to keep an eye on as we head into the new year.

Cannabis Investors Need to Focus on Mexico

Breaking: President Says to Expect Pot Legalization in 6 Months

By Jeff Siegel on December 6, 2018
Energy and Capital editor Jeff Siegel shares what the president just personally told him about cannabis legalization in Mexico. And his special algorithm that identifies the best-in-breed cannabis stocks throughout the world will help you profit from this coming boom.

The Top 6 Cannabis Stocks for 2019

6 Pot Stocks to Own for 2019

By Jeff Siegel on November 29, 2018
It's time to capitalize on the U.S. cannabis market. While 2018 was a big year for cannabis across the globe, in 2019, we're going to see, for the first time, a real push for U.S. legalization on the federal level. Here are the stocks you need to keep an eye on...

Investing in the End of the Opioid Epidemic

How to Profit from America’s Deadliest Epidemic

By Jeff Siegel on November 23, 2018
Capitalism, not the government, will solve the opioid epidemic. Jeff Siegel looks at the latest government attempt to find a scapegoat and the companies that will really be pivotal in ending this epidemic... and making you money in the process.

Medical Cannabis Stocks Are Ripe for the Picking

Weed, Money, and Medicine: Why YOU Need it Every Day

By Jeff Siegel on November 15, 2018
Now that the adult use of cannabis is legal in Canada, soon to be legal in Mexico, and now legal in 10 states in the U.S., sometimes it can be easy to forget that cannabis is medicine. But that’s exactly what it is. And as investors, we have to remember that there’s a lot of money to be made in medicine.